300404.SZ
博济医药
SZSE · M 科研服务 · CN
CNY 14.15
−1.94%Margins
Gross margin
26.9%
EBITDA margin
6.8%
EBIT margin
5.0%
Net margin
4.5%
FCF margin
5.2%
4.0%
Return on equity
2.6%
Return on assets
4.3%
Return on invested capital
0.58x
Asset turnover
CNY 67.1M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026